XenoGesis will be attending the DMDG Joint Meeting, held in partnership with the Swedish Academy of Pharmaceutical Sciences.
The DMDG Joint Meeting, which will be held in Gothenburg, is set to take place on the 16th – 18th October, and will cover topics including strategies for PKPD modelling in drug discovery and development; new technologies in DMPK and; regulatory considerations.
XenoGesis will be presenting a scientific poster at the meeting.
The DMDG is a scientific learned society that provides a forum in which members from the Pharmaceutical sector and contract research organisations actively engaged in studies on drug metabolism, pharmacokinetics and related disciplines may informally and privately discuss topics and problems of mutual interest.
For more information, click here.